Align Technology Q3 2026 Earnings: Margins Improve despite Systems Weakness

Align Technology (NASDAQ: ALGN) reported Q3 fiscal 2026 revenue of $1.0148 billion, up 1.9% year over year, while GAAP diluted EPS rose to $1.90 from $0.78 for the quarter ended September 30, 2026. Clear Aligner growth offset lower Imaging Systems and CAD/CAM Services revenue, while expense discipline and productivity helped expand operating margins despite pricing, transportation, and currency pressure.

Core Financial Results

Revenue growth was concentrated in Clear Aligners, while the Systems and Services business contracted. Earnings improved much faster than revenue: GAAP net income rose 138.0%, while non-GAAP net income increased 5.2%, making the underlying margin performance important for assessing the quarter.

GAAP operating margin expanded by 7.0 percentage points to 16.7%. On an adjusted basis, operating margin increased by 0.5 percentage points to 24.4%, or by approximately 1.4 percentage points at constant currency.

Foreign exchange reduced reported revenue by approximately $5.0 million year over year and lowered GAAP diluted EPS by approximately $0.24.

Business and Segment Performance

Clear Aligner revenue increased more slowly than case volume, consistent with management’s comments about lower average selling prices and geographic and product mix. Volume benefited from record doctor submitters, record third-quarter shipments, a 3.4% increase in doctor utilization, and broad-based international growth.

North American orthodontist shipments increased year over year for the first time in six quarters. Shipments through dental service organizations also rose at a double-digit rate across orthodontist and general-practitioner customers.

Systems and Services remained the principal top-line weakness. The revenue decline came even as iTero scanner placements—including leased, rented, and certified pre-owned systems—increased at a double-digit rate and the global number of placed systems surpassed 157,000.

Profitability, Liquidity, and Capital Returns

Gross-margin pressure came from higher fuel-related transportation costs, lower Clear Aligner selling prices, and geographic and product mix. Currency reduced GAAP gross margin by approximately 0.8 percentage points year over year; excluding that effect, the margin would have been approximately 69.5%. Non-GAAP gross margin was flat at 70.4% on a reported basis but increased approximately 0.7 percentage points at constant currency.

Expense management and productivity improvements helped offset those pressures at the operating level. Non-GAAP operating margin reached 24.4%, while currency reduced GAAP operating margin by approximately 1.5 percentage points. GAAP operating income also included an unfavorable $5.6 million accrual related to UK value-added tax.

Cash and cash equivalents totaled $1.1449 billion at September 30, up from $1.1026 billion at June 30. Align also had $300.0 million available under its revolving credit facility.

During the quarter, the company repurchased approximately 627,300 shares at an average price of $164.73. At quarter-end, $630.0 million remained under the $1.0 billion repurchase authorization announced in April 2025.

Earnings Guidance

Align’s fourth-quarter outlook reflects continued softness in discretionary healthcare spending and capital-equipment investment. The company expects modest year-over-year Clear Aligner volume growth but continued pressure on average selling prices.

For fiscal 2026, management expects Clear Aligner growth to remain the primary revenue driver. The projected 23.7% non-GAAP operating margin remains consistent with previous guidance.

Align expects to repurchase up to $300 million of shares in Q4 and approximately $500 million during fiscal 2026.

Management Perspective

Management said dental and orthodontic demand continued to be affected by softer discretionary healthcare spending and capital-equipment investment. Preliminary planning for 2027 assumes that operating conditions remain broadly consistent with the current environment and does not depend on a consumer recovery, although management still anticipates revenue growth and margin expansion.

The company is also broadening its direct 3D-printing platform. Its pipeline includes NXT Technology, the Invisalign Specifix attachment system, and a U.S. pilot of the Invisalign Sports Guard made from an iTero digital scan. These initiatives are intended to expand the applications of Align’s digital platform beyond its existing aligner and scanning products.

Risks Investors Need to Watch

• Discretionary spending remains soft: Continued pressure on consumer healthcare spending could limit Invisalign case growth, while cautious capital investment by dental practices could weigh on scanner and services revenue.
• Pricing and mix are constraining gross margin: Lower Clear Aligner ASPs, product and geographic mix, and transportation costs offset part of the benefit from higher case volume.
• Systems revenue continues to contract: Imaging Systems and CAD/CAM Services revenue declined 7.6%, creating a meaningful offset to Clear Aligner growth despite increased scanner placements.
• Currency remains a material headwind: Foreign exchange reduced quarterly revenue, gross margin, operating margin, and EPS, making reported results more sensitive to currency movements.

Summary

Align Technology’s Q3 fiscal 2026 results showed modest revenue growth but substantially better profitability. Higher Clear Aligner volume, improved doctor utilization, and expense discipline offset weakness in Systems and Services as well as pricing, transportation, and currency pressure. Investors’ next focus will be whether Align can sustain aligner volume growth, stabilize its systems business, and deliver the margin levels outlined in its Q4 and full-year guidance.